Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06744790 · ClinicalTrials.gov registry record

Advanced Prediction of Respiratory Depression Episode Using the Linshom Continuous Predictive Respiratory Sensor

A clinical trial of Respiratory Complication and Post Surgical Respiratory Failure, sponsored by Linshom Medical.

Recruiting
Registry status
320
Enrollment target
1
Study location

NCT06744790: Recruiting study of Respiratory Complication and Post Surgical Respiratory Failure, sponsored by Linshom Medical.

NCT06744790 is a study of Respiratory Complication and Post Surgical Respiratory Failure that is actively recruiting participants, run by Linshom Medical. The registered enrollment target is 320 participants, above the 36-participant average among 3 other Respiratory Complication trials with a reported enrollment target (789% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06744790, a study of Respiratory Complication and Post Surgical Respiratory Failure, is actively recruiting participants, sponsored by Linshom Medical.

RECRUITING
Registry status
320 participants
Enrollment target
1
Study location

Study Summary

Investigators will enroll 320 patients who will undergo non-cardiac surgery, receive supplemental oxygen via face mask, and will be on a continuous pulse oximetry monitor in the Post Anesthesia Care Unit (PACU). The enrollment criteria were adapted from a previous study that showed SpO2 values seriously underestimated the severity of post-operative hypoxemia in patients with and without specific risk factors for hypoxemia. Research personnel will screen and ensure that each subject meets the enrollment criteria, and the informed consent is properly executed. Upon arrival to the PACU, each subject will be fitted with oxygen mask containing the Linshom sensor, which will be connected to a Linshom monitor for data collection. A side stream capnography line will be connected to the same face mask and the capnography data will be collected on the Zoe Medical 740 SELECT™ monitor. Additionally, two pulse oximeters will be applied to the same hand (non- NIBP arm), one of which will be connected to a hospital monitor (SoC) and the other to a Zoe Medical 740 SELECT™ monitor. The Linshom and 740 SELECT™ monitors will collect data once every second. Research personnel will then initiate the Linshom CPRM baseline mode and begin recording any clinical intervention (e.g., medications, oxygen delivery change, and stimulation upon detection of changes in patient's condition) that is performed by the PACU staff, paying close attention to, and recording of time at which those interventions occurred. Data collection will be performed throughout the subject's entire PACU stay. The CPRM data collection will be performed passively while the patient is monitored via SoC and will not interfere with clinical interventions that may take place during the data collection. Clinical staff in the PACU will be blinded to the Linshom CPRM data as well as pulse oximetry (non-SOC monitor) and capnography data collected.

Primary Outcome

The primary analysis will be to assess non-inferiority of Linshom + SOC to SOC alone (nurse monitoring + pulse oximetry) with respect to the time (in minutes) prior to RDE that it was predicted that an RDE would occur.This analysis will be performed on patients with RDE. The statistical test to be used will be a paired t-test for non-inferiority of means.

Interventions

  • DEVICE Linshom Continuous Predictive Respiratory Monitoring

Study Locations (1)

Maryland

  • University of Maryland Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2023-06-21
Est. Completion 2025-06-16
Linshom Medical

1 total trials

What NCT06744790 shows while recruiting

NCT06744790 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, above the 36-participant average among 3 other Respiratory Complication trials with a reported enrollment target (789% higher).

The record links to 2 conditions, with Respiratory Complication appearing as the primary indexed condition, and to 1 intervention - of which Linshom Continuous Predictive Respiratory Monitoring is the first listed.

NCT06744790 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06744790 about?

NCT06744790 is a clinical study titled "Advanced Prediction of Respiratory Depression Episode Using the Linshom Continuous Predictive Respiratory Sensor". Investigators will enroll 320 patients who will undergo non-cardiac surgery, receive supplemental oxygen via face mask, and will be on a continuous pulse oximetry monitor in the Post Anesthesia Care Unit (PACU). The enrollment criteria were adapted from a previous study that showed SpO2 values serio...

What is the current status of trial NCT06744790?

This trial is currently recruiting. The enrollment target is 320 participants. The study started on 2023-06-21. Estimated completion is 2025-06-16.

What conditions does trial NCT06744790 study?

This clinical trial studies the following conditions: Respiratory Complication, Post Surgical Respiratory Failure.

What interventions are being tested in trial NCT06744790?

The interventions under investigation include: Linshom Continuous Predictive Respiratory Monitoring (DEVICE).

Who is sponsoring clinical trial NCT06744790?

This trial is sponsored by Linshom Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06744790 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02763683 · 320 participants

    Investigations of Dementia in Parkinson Disease

  • NCT03331198 · 320 participants · Phase 1

    Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  • NCT03458832 · 320 participants

    Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

  • NCT03551951 · 320 participants

    Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06744790, the US trial registry maintained by the National Library of Medicine. NCT06744790 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.